Tower Research Capital (TRC)’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$324K Sell
12,658
-12,703
-50% -$299K 0.01% 1336
2026
Q1
$379K Buy
25,361
+8,914
+54% +$152K 0.01% 1126
2025
Q4
$239K Buy
16,447
+9,486
+136% +$165K 0.01% 1303
2025
Q3
$125K Sell
6,961
-25,882
-79% -$380K ﹤0.01% 1827
2025
Q2
$561K Buy
32,843
+24,083
+275% +$241K 0.02% 885
2025
Q1
$63.4K Buy
8,760
+5,842
+200% +$66.5K ﹤0.01% 2054
2024
Q4
$41K Sell
2,918
-22,494
-89% -$332K ﹤0.01% 2686
2024
Q3
$301K Buy
+25,412
New +$263K 0.01% 1252
2024
Q2
Sell
-41,615
Closed -$147K 5723
2024
Q1
$147K Buy
+41,615
New +$144K ﹤0.01% 1612

Other funds holding CORZ

Tower Research Capital (TRC)'s CORZ Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Core Scientific (CORZ) stake by 50% in Q2 2026, selling an estimated $299K and leaving 12,658 shares worth $324K. The position accounts for 0.01% of the portfolio, ranked #1336.

Tower Research Capital (TRC) first reported a position in CORZ in Q1 2024 and has held it in 9 quarters since. The position peaked at $561K in Q2 2025. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Tower Research Capital (TRC) held 12,658 shares of Core Scientific worth $324K as of Q2 2026.
  • Tower Research Capital (TRC) sold 12,703 Core Scientific shares in Q2 2026, an estimated $299K.
  • Core Scientific made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #1336 holding.
  • Tower Research Capital (TRC) first reported a position in Core Scientific in Q1 2024 and has held it in 9 quarters since.
  • Tower Research Capital (TRC)'s Core Scientific position peaked at $561K in Q2 2025.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.